Substituted (3S, 4R)/(3R, 4S)-Statines compound and preparation method thereof
A compound and said technology are applied in the field of key fragment substitution/-Statines compounds and their preparation, which can solve the problems of harsh preparation conditions, lack of universality, and difficulties in Statine preparation, and achieve high yield, simple route, and easy operation. simple effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] Synthesis of (2S,3R)-tert-butoxycarbonyl 2-ethyl 3-tert-butyldimethylsilyloxy 5-carbonylpyrrole (compound 2a)
[0024] The initial material 1 was prepared according to our previous literature (Org. Lett. 2014, 16, 4328-4331, Org. Chem. Front. 2015, 2, 1485–1499). Compound 1 (1g, 2.86mmol) was dissolved in 12mL of tetrahydrofuran, magnesium powder (224mg, 9.16mmol) was added at 0°C, bromoethane (935mg, 8.58mmol) was added dropwise, and the temperature was naturally raised to react for 12 hours. After quenching with ammonium chloride, extract with ethyl acetate, dry, and concentrate to obtain a crude product, which is dissolved in 10 mL of dichloromethane and added to Boc 2 O (1.25g, 5.72mmol), DMAP (350mg, 2.86mmol) and triethylamine (2.0mL, 14.30mmol) were reacted for 24 hours, concentrated and purified by silica gel column to give white solid 2a (384mg, 39%). 1 H NMR (400MHz, CDCl 3 )δ4.09(d, J=5.2Hz, 1H), 3.87(dd, J=9.6, 3.8Hz, 1H), 2.77(dd, J=17.6, 5.3Hz, 1H), 2.34...
Embodiment 2
[0032]Synthesis of (2S,3R)-tert-butoxycarbonyl-2-(4-methylphenyl)-3-tert-butyldimethylsilyloxy 5-carbonylpyrrole (compound 2b)
[0033] Compound 1 (1g, 2.86mmol) was dissolved in 12mL of tetrahydrofuran, magnesium powder (224mg, 9.16mmol) was added at 0°C, 4-bromotoluene (1.47g, 8.58mmol) was added dropwise, and then the temperature was naturally raised for 3 hours. After quenching with saturated ammonium chloride, extract with ethyl acetate, dry, and concentrate to obtain a crude product, which is dissolved in 10 mL of dichloromethane and added to Boc 2 O (1.25g, 5.72mmol), DMAP (350mg, 2.86mmol) and triethylamine (2.0mL, 14.30mmol) were reacted for 24 hours, concentrated and purified by silica gel column to give white solid 2a (615mg, 53%). 1 H NMR (600MHz, CDCl 3 )δ7.19-7.15(m,2H),7.08-7.04(m,2H),4.96-4.92(m,1H),4.08(ddd,J=5.5,2.2,1.2Hz,1H),2.85(dd, J=17.5,5.6Hz,1H),2.39(ddd,J=17.5,1.9,0.8Hz,1H),2.35(s,3H),1.32(s,9H),0.89(s,9H),0.08(s ,3H),0.05(s,3H).
[0034] Synthesis...
Embodiment 3
[0041] Synthesis of (2S,3R)-tert-butoxycarbonyl-2-(3-methylphenyl)-3-tert-butyldimethylsilyloxy 5-carbonylpyrrole (compound 2c)
[0042] Compound 1 (1g, 2.86mmol) was dissolved in 12mL of tetrahydrofuran, magnesium powder (224mg, 9.16mmol) was added at 0°C, 3-bromotoluene (1.47g, 8.58mmol) was added dropwise, and the temperature was naturally raised for 3 hours. After quenching with saturated ammonium chloride, extract with ethyl acetate, dry, and concentrate to obtain a crude product, which is dissolved in 10 mL of dichloromethane and added to Boc 2 O (1.25g, 5.72mmol), DMAP (350mg, 2.86mmol) and triethylamine (2.0mL, 14.30mmol) were reacted for 24 hours, concentrated and purified by silica gel column to give white solid 2c (696mg, 60%). 1 H NMR (400MHz, CDCl 3 )δ7.28-7.22(m,1H),7.15-7.08(m,1H),7.01-6.93(m,2H),4.98-4.88(m,1H),4.10(ddd,J=5.6,2.4,1.5 Hz,1H),2.86(dd,J=17.4,5.7Hz,1H),2.40(ddd,J=17.5,2.1,0.8Hz,1H),2.34(s,3H),1.31(s,9H),0.89 (s,9H),0.08(s,3H),0.05(s,3H).
[004...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


